Sentences with phrase «state of cancer research»

Roads and roadblocks, both literal and metaphorical, figured into a panel discussion on the state of cancer research and care in the...

Not exact matches

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

While study results indicated that combining capsaicin with the chemicals «might promote cancer cell survival,» the report clearly stated that the control group of mice treated only with capsaicin ``... did not induce any skin tumors...» In addition, the study repeatedly cited other research studies in which the anti-cancer properties of capsaicin were solidly demonstrated.

More than three decades after manufacturers stopped making children's pajamas with a flame retardant suspected of causing cancer, new research suggests the same chemical has become the most widely used fire - resistant compound in upholstered furniture sold throughout the United States.

In this talk, Natalie presents the latest state of research into the links between breast feeding and breast cancer, including the latest evidence for risk reduction and our understanding of how pregnancy - associated breast cancer develops.

Ex-Assembly Speaker Sheldon Silver has subpoenaed key documents from a doctor who allegedly took $ 500,000 worth of state cancer - research grants in exchange for referring patients to Silver's law firm, new...

Testimony and other evidence showed that Mr. Silver had arranged to have the State Health Department award two grants totaling $ 500,000 to Dr. Taub, whose research focused on mesothelioma, a deadly form of cancer related to asbestos exposure.

Prosecutors allege that Silver simultaneously funneled $ 500,000 in state funds for cancer research to Taub's clinic, but the firm was not aware of this.

The doctor at the center of the Silver scandal «disapproved» of him and his law firm and referred cancer patients there only as long as the former speaker was funneling him state money for research, the court papers claim.

After years of struggle over state funding for Roswell Park Cancer Institute, Cuomo last week proposed the first state budget in years with no cuts in aid to the Buffalo research hospital.

Over the years, Roswell Park has also become recognized as one of the United States» leading cancer treatment and research centers, and it recruits physicians and researchers from across the world to come live and work in the Buffalo area.

Dr. Robert Taub, the director of Columbia's Mesothelioma Center, which handles asbestos - related cancer, referred his patients to Silver's law firm in exchange for the speaker steering $ 500,000 in state money to his research and providing favors to his family, according to a criminal complaint and sources.

New York City Councilman Antonio Olivieri, who died of cancer in 1980 at age 39, had lobbied for state medical marijuana use for therapeutic research.

Taub also reiterated his motivation for referring patients to Silver was born out of a desire to convince Weitz & Luxenberg to begin donating to cancer research — specifically his mesothelioma research center — and that it was only after his referrals came that he was advised by a mutual acquaintance that he write Silver about state funding.

U.S. Attorney Preet Bharara's office contends Silver traded state grant money for Taub's research clinic at Columbia University for Taub's referrals of mesothelioma cancer patients to Weitz & Luxenberg, Silver's law firm.

Earlier this year, Governor Cuomo indicated state funding for Roswell would come to an end by 2014, but budget negotiations have given the cancer research facility a reprieve, of sorts.

Taub, who got nearly $ 500,000 in state money for his research funneled to him from Silver, didn't like that the firm failed to give any of the millions it made off cancer cases to mesothelioma research.

Dr. Taub, 79, a leading oncologist dedicated to cancer research, sent patients to Mr. Silver and his law firm, and Dr. Taub received state grants with the help of Mr. Silver, 71, then the speaker of the New York Assembly.

The doctor at the center of the corruption charges against former Assembly Speaker Sheldon Silver «disapproved» of him and his law firm and referred cancer patients there only as long as Silver was funneling him state money for research, new court papers claim.

Beyond the university - based experts who also came from Harvard and the University of Pittsburgh, U.S. symposium participants in Havana were from Memorial Sloan - Kettering Cancer Center, the Roswell Park Cancer Center, both in New York State, the Moffitt Cancer Center in Florida and the Ponce Research Institute in Puerto Rico, as well as the U.S. Department of Health & Human Services, the National Cancer Institute, and the Centers for Disease Control and Prevention..

«Cancer research is a high priority for both countries — just witness the launch of a new National Cancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cCancer research is a high priority for both countries — just witness the launch of a new National Cancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cCancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cancercancer.

Other conference organizers, including the American College of Rheumatology, the American Association for Cancer Research (AACR), several special interest groups of the Association for Computing Machinery in the United States, and the European Molecular Biology Organization (EMBO) have provided similar child - care services at their meetings.

Collaborators in the research include Texas A&M University; University of Missouri - Columbia; University of California - Davis; Wellcome Trust Sanger Institute in the United Kingdom; Pompeu Fabra University in Spain; Centro de Analisis Genomico in Spain; Bilkent University in Turkey; Indiana Univeristy; Center for Cancer Research in Maryland; St. Petersburg State University in Russia; and Nova Southeastern University in research include Texas A&M University; University of Missouri - Columbia; University of California - Davis; Wellcome Trust Sanger Institute in the United Kingdom; Pompeu Fabra University in Spain; Centro de Analisis Genomico in Spain; Bilkent University in Turkey; Indiana Univeristy; Center for Cancer Research in Maryland; St. Petersburg State University in Russia; and Nova Southeastern University in Research in Maryland; St. Petersburg State University in Russia; and Nova Southeastern University in Florida.

Led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in tumor cells might predict patients» response to radiation therapy.

An experimental drug in early development for aggressive brain tumors can cross the blood - brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

She received her postdoctoral training in colorectal cancer genomics at the Institute for Genomic Research (now part of the J. Craig Venter Institute) in 2000 and her graduate training in biochemical pharmacology from the State University of New York in Buffalo.

A new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibcancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibitors.

In a continuation of this work, Goldman is also using mathematical modeling to pursue the most effective dose of chemotherapy to induce the vulnerable transition state of the cancer cell demonstrated in this research.

With obesity rates climbing during the past 20 years within the United States and colon cancer being the second - leading killer of men and women in the nation, these facts compelled Fenton and her team to conduct research which could identify the specific biomarkers of obesity and early - stage colon cancer and help in prevention efforts.

She notes that biotech firms are investing heavily in immunotherapy research, and about 40 percent of the roughly 6,000 cancer clinical trials taking place in the United States today include some form of immunotherapy.

According to the University of Utah's drug information service, 198 drug shortages had been reported in the United States by late August this year, 15 of which are cancer drugs required for clinical research.

The World Cancer Research Fund estimates that about one quarter to one third of all cancers in the United States can be attributed to diet and insufficient physical activity, as well as overweight and obesity.

A molecule in cells that shuts down the expression of genes might be a promising target for new drugs designed to treat the most frequent and lethal form of brain cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — Jcancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — JCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — JCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

Today, e-cigarettes earned another kind of notice: Two of the largest cancer science and treatment groups in the United States called on the government to start regulating «electronic nicotine delivery systems» and step up research on the health effects of vaping.

The current authors evaluated the effects of ADT on mental and emotional well - being in men diagnosed with localized prostate cancer using data from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry, which consists of data from largely community - based practices across the United Scancer using data from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry, which consists of data from largely community - based practices across the United SCancer of the Prostate Strategic Urologic Research Endeavor) registry, which consists of data from largely community - based practices across the United States.

A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases.

With an M.A. in human genetics and molecular biology from Johns Hopkins University School of Medicine and a B.S. in biochemistry from New Mexico State University, Cordova has held research internships at those institutions as well as at the Fred Hutchinson Cancer Research Center and at the University of Texas - research internships at those institutions as well as at the Fred Hutchinson Cancer Research Center and at the University of Texas - Research Center and at the University of Texas - Houston.

Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet - B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

The audience will learn about the current state of breast cancer research, how data generated by NGS gene panels target variants of interest and have been developed and used in routine laboratory research, and the broader issues of breast cancer education, awareness, and community services.

Obama, he said, elevated the role of science and technology advisers throughout the executive branch, put in place plans to mitigate and prepare the United States for the impacts of climate change, set up health research initiatives to tackle such priorities as cancer and brain research, worked with international partners on scientific issues and used the White House as a platform from which to herald science and education, particularly for children.

Genetically analysing lesions in the food pipe could provide an early and accurate test for esophageal cancer, according to research led by Queen Mary University of London (QMUL), Academic Medical Center in Amsterdam and Arizona State University.

In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutacancer patients with B - raf mutations.

Breast Cancer Awareness Month highlights the continuing research on this type of cancer, the second most common cancer in the United SCancer Awareness Month highlights the continuing research on this type of cancer, the second most common cancer in the United Scancer, the second most common cancer in the United Scancer in the United States.

But Stratton is convinced that in a few years time, once the full pattern of the cancer genome is revealed, his next group of students will ask the same question about the present state of research.

Arizona State University Army Research Lab, Weapons and Materials Research Directorate Baylor School of Medicine Carnegie Mellon University Case Western Reserve University CIIT Centers for Health Research Columbia University Cornell University Emory University School of Medicine Fred Hutchinson Cancer Research Center J. David Gladstone Institute Harvard University Medical School Indiana University, Bloomington Johns Hopkins School of Medicine Los Alamos National Laboratory Lawrence Livermore National Laboratory Louisiana State University Health Sciences Center Massachusetts General Hospital Massachusetts Institute of Technology McGill University MCP Hahnemann Medical School Medical College of Georgia Medical College of Wisconsin Microsoft NCI NIEHS NIH NOAA New York University School of Medicine Penn State University College of Medicine Pfizer Rockefeller University Rowland Institute for Science Seattle Biomedical Research Institute St. Jude Children's Research Hospital Stanford University USEPA / National Risk Management Research Lab University of Alabama, Birmingham University of California, Berkeley University of California, Los Angeles University of California, San Diego University of California, San Francisco University of Chicago University of Cincinnati College of Medicine University of Colorado at Boulder University of Georgia University of Illinois, Chicago University of Illinois, Urbana - Champagne University of Maryland University of Medicine and Dentistry of New Jersey University of Michigan University of Minnesota University of New Mexico University of North Carolina, Chapel Hill University of Pennsylvania University of Rochester School of Medicine and Dentistry University of Texas, Austin University of Texas Medical Branch University of Toronto University of Wisconsin, Madison Vanderbilt University Virginia Tech Yale University

Since the Spanish government lured the Madrid - born scientist back from the United States 13 years ago to create the National Cancer Research Centre, Barbacid has been involved in a series of conflicts with the government and his staff members.

Eran Andrechek, a physiology professor in the College of Human Medicine at Michigan State University, has discovered that many of the various models used in breast cancer research can replicate several characteristics of the human disease, especially at the gene level.

From my postdoctoral work at the Cancer Research Institute at Arizona State University in Tempe, US, to the 5 years I spent working at Griffith University's Queensland Pharmaceutical Research Institute (now called AstraZeneca R&D Griffith University) in Brisbane, Australia, my research has gravitated towards the pharmaceutical side of natural product rResearch Institute at Arizona State University in Tempe, US, to the 5 years I spent working at Griffith University's Queensland Pharmaceutical Research Institute (now called AstraZeneca R&D Griffith University) in Brisbane, Australia, my research has gravitated towards the pharmaceutical side of natural product rResearch Institute (now called AstraZeneca R&D Griffith University) in Brisbane, Australia, my research has gravitated towards the pharmaceutical side of natural product rresearch has gravitated towards the pharmaceutical side of natural product researchresearch.

A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

«Our research shows that the protein GSK3 plays a crucial role in helping B cells meet the energy needs of their distinct states,» says Robert Rickert, Ph.D., director of the Tumor Microenvironment and Cancer Immunology Program at Sanford Burnham Prebys Medical Discovery Institute (SBP).